Skip to content
Adlore, Inc.

SenLore™ is an investigational device, not yet available for sale or cleared by the FDA.

Foundational research

Research & evidence

SenLore is built on a 15-year DFU research line. The numbers below are comparable to that published clinical series — not a claim of what a finished SenLore product will do for any individual patient, and not FDA clearance.

Hospital and published ES + heat studies; not an FDA-cleared claim.

Artist rendition of the breadboard electrode-insole prototypePrototype rendering
Prototype rendering — investigational device, not FDA-cleared.Early electrode-insole R&D. Enhanced from the bench photo; not a finished product.
Dr. Daryl Lawson holding the SenLore prototype boot with Western Michigan University physical therapy researchers
WMU Doctor of Physical Therapy program research team. Student names withheld.

0%

Healing at 4 weeks in the published ES + heat series vs. ~25% standard of care (N=91)

0%

Ulcer-area reduction at 4 weeks in the NC Biotech grant study vs. 24% standard of care

0

Peer-reviewed papers on the underlying research

0

Granted U.S. patents on the platform

Hospital and published ES + heat studies; not an FDA-cleared claim.

Three rungs of evidence

The Lawson/Petrofsky line found heat plus electrical stimulation improved blood flow and wound-area reduction beyond heat alone in chronic diabetic ulcers. The diabetic perfusion response stayed blunted versus non-diabetic subjects — that gap is the clinical problem the boot is built to treat.

SenLore prototype boot during a research session at Western Michigan University
Research-and-development prototype on a volunteer. Not a finished commercial product. For internal review; confirm consent before public launch.
Electrical stimulation wrap on a knee with a handheld stimulator, from earlier Lawson research
Historical lab photo from the heat and stimulation research line — a knee ES setup, not the SenLore boot.

Elon University — grant origin

Before Western Michigan University, Dr. Lawson was associate professor of physical therapy education at Elon University. In 2017, Elon reported a $95,500 North Carolina Biotechnology Center grant for a therapeutic boot, with prototype work described as happening in Elon’s Maker Hub and Chris Arena as the engineering collaborator (then assistant professor of engineering at Elon). University coverage from that period already pointed toward patent and FDA pathway work — a long game, not a new idea.

These are links to Elon’s original coverage. They are institutional history, not SenLore FDA results.

Doctoral dissertation

Dr. Daryl Lawson, DSc (Loma Linda University), on chronic, non-healing wounds in people with diabetes — seven years of DFU work with Jerrold Petrofsky, PhD, in a hospital studies line of inquiry.

Patents

Four granted U.S. patents: US 11,013,910; US 12,011,584; US 11,338,128; US 12,403,299. EU granted; Canada pending. Claims span stimulation, heat, off-loading, and monitoring — a platform, not a single-feature patent.

Publications

This research line is documented across and , and underlies . Full list: daryllawson.academia.edu/research

How this informs SenLore

These studies are the scientific basis for combining heat and electrical stimulation. The intended mechanism, 4-part home system, and prototype photography live on the SenLore page.

Research timeline

  1. Clinical practice

    Renown Medical Center and Kaiser Hayward

    Twelve years of orthopedic and wound-management practice in Reno, plus an orthopedic residency at Kaiser Hayward, before Lawson’s academic career.

  2. Doctoral research

    Loma Linda University

    Dr. Lawson’s DSc dissertation on chronic, non-healing wounds in people with diabetes.

  3. 2007–2013

    Peer-reviewed heat and stimulation studies

    Published work on biphasic stimulation in a warm room, local versus global heat, combination therapy for diabetic foot ulcers, and biphasic versus monophasic waveforms.

  4. 2015–2017

    Elon University

    Associate professor of physical therapy education. A $95,500 North Carolina Biotechnology Center grant supported therapeutic-boot work with Chris Arena (then assistant professor of engineering at Elon). Prototype work was described as happening in Elon’s Maker Hub.

  5. IP

    Patents

    Academic patents from the dissertation work later underpin company-assigned filings. Exact issued vs. pending counts remain marked for confirmation.

  6. 2018–

    Western Michigan University

    Continued development with WMU collaborators, including flexible sensor/electrode layers designed to sit inside the boot.

  7. 2019

    Adlore founded

    Company formed to develop SenLore™ as an investigational wearable for diabetic foot ulcers.

  8. 2026

    University of Nevada, Reno

    Founding chair and director of UNR’s Doctor of Physical Therapy program. First cohort anticipated fall 2027, pending CAPTE candidacy.

Selected publications

  • Lawson D, Petrofsky J. Randomized study of biphasic electrical stimulation in a warm room. Med Sci Monit. 2007. PubMed
  • Petrofsky JS, Lawson D, Berk L, Suh H. Local heat and electrical stimulation for diabetic foot ulcers. J Diabetes. 2010. DOI
  • Petrofsky JS, Lawson D, et al. Local versus global heat in chronic wounds in diabetes. Diabetes Technol Ther. 2007. DOI
  • Suh H, Petrofsky J, et al. Multi-electrode design for chronic non-healing wounds in diabetes. Diabetes Technol Ther. 2009.
  • Panahi M, et al., including Lawson D and Atashbar MZ. Flexible smart wearable oximeter insole. IEEE J. Flex. Electron. 2022. DOI
  • Lawson D, Petrofsky JS, et al. Monophasic versus biphasic current. J Wound Ostomy Continence Nurs. 2013. DOI

SenLore™ is an investigational device, not yet available for sale or cleared by the FDA.